Ahmed Khalaf

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum

Chronic Myeloid Leukemia

Drug Administration

Top Venues

Science translational medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed Khalaf, Lucie de Beauchamp, Eric R Kalkman, Kevin M Rattigan, Ekaterini Himonas, Joe Jones, Daniel James, Engy Shokry Abd Shokry, Mary T Scott, Karen M Dunn, Saverio Tardito, Mhairi Copland, David Sumpton, Emma Shanks, G Vignir Helgason
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia. Science translational medicine 16 (751) (2024)
Ahmed Khalaf, Lucie de Beauchamp, Eric R Kalkman, Kevin M Rattigan, Ekaterini Himonas, Joe Jones, Daniel James, Engy Shokry Abd Shokry, Mary T Scott, Karen M Dunn, Saverio Tardito, Mhairi Copland, David Sumpton, Emma Shanks, G Vignir Helgason
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia. Science translational medicine 16 (751) (2024)
Kevin M Rattigan, Zuzana Brabcova, Daniele Sarnello, Martha M Zarou, Kiron Roy, Ryan Kwan, Lucie de Beauchamp, Amy Dawson, Angela Ianniciello, Ahmed Khalaf, Eric R Kalkman, Mary T Scott, Karen M Dunn, David Sumpton, Alison M Michie, Mhairi Copland, Saverio Tardito, Eyal Gottlieb, G Vignir Helgason
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells. Nature communications 14 (1) (2023)